MedPath

Role of Pathyadi Churna and Baluka Sveda in patients of Rheumatoid arthrits vis-a-vis Amavata

Phase 2
Conditions
Health Condition 1: M068- Other specified rheumatoid arthritisHealth Condition 2: M057- Rheumatoid arthritis with rheumatoid factor without organ or systems involvementHealth Condition 3: M060- Rheumatoid arthritis without rheumatoid factor
Registration Number
CTRI/2024/03/064217
Lead Sponsor
Department of Kayachikitsa
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients aged between 30-60 years of age of both the sex

Diagnosed cases of Amavata based on symptoms and signs as described in Madava Nidana and EULAR criteria of RA

Patients with H/O more than 1 year with established disease

Sero-positive and sero-negative both cases will be included

Exclusion Criteria

1 Patients below the age of 30 and above 60 years of age

2 Patients suffering from systemic disorders (like Diabetes Mellitus, Cardiac diseases, Pulmonary Tuberculosis, Essential Hypertension, SLE, Infectious Arthritis, Hypertrophic Arthropathy)

3 Pregnant & Lactating women

4 Patients with major complications are also excluded

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Relief in signs and symptoms of the disease. The main signs and symptoms are follows: <br/ ><br>stiffnes <br/ ><br>lack of eating desire <br/ ><br>fever <br/ ><br>thirst <br/ ><br>lethargy <br/ ><br>swelling <br/ ><br>heaviness in body and joints <br/ ><br>indigestion <br/ ><br>Timepoint: 63 days with Follow up at 21 days interval <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
Changes in following: <br/ ><br>1 On the basis of clinical sign and symptoms of the grading scale (0-3) <br/ ><br>2 VAS scale <br/ ><br>3 Ama strength grading scale <br/ ><br>4 Assessment of severity of RA <br/ ><br>5 Hematological investigations <br/ ><br>(CRP, RA factor,Anti CCP , CBC, LFT,RFT ,)Timepoint: 63 days with Follow up at 21 days interval <br/ ><br>
© Copyright 2025. All Rights Reserved by MedPath